Cargando…
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
Ubiquitin proteasome activity is suppressed in enzalutamide resistant prostate cancer cells, and the heat shock protein 70/STIP1 homology and U-box-containing protein 1 (HSP70/STUB1) machinery are involved in androgen receptor (AR) and AR variant protein stabilization. Targeting HSP70 could be a via...
Autores principales: | Xu, Pengfei, Yang, Joy C., Ning, Shu, Chen, Bo, Nip, Christopher, Wei, Qiang, Liu, Liangren, Johnson, Oleta T., Gao, Allen C., Gestwicki, Jason E., Evans, Christopher P., Liu, Chengfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162009/ https://www.ncbi.nlm.nih.gov/pubmed/36773708 http://dx.doi.org/10.1016/j.phrs.2023.106692 |
Ejemplares similares
-
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2018) -
Multivalent protein–protein interactions are pivotal regulators of eukaryotic Hsp70 complexes
por: Johnson, Oleta T., et al.
Publicado: (2022) -
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
por: Xu, Pengfei, et al.
Publicado: (2023) -
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
por: Semenas, Julius, et al.
Publicado: (2013) -
Pathways of allosteric regulation in Hsp70 chaperones
por: Kityk, Roman, et al.
Publicado: (2015)